Addex Therapeutics Ltd Adjustments For Finance Income Cost
Addex Therapeutics Ltd (ADXN) reported Adjustments For Finance Income Cost of -CHF 33.40 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceIncomeCost · last filed 2025-09-30
| Period end | Adjustments For Finance Income Cost 6 month | Adjustments For Finance Income Cost 12 month |
|---|---|---|
| 2025-06-30 | -33.40K CHF 6-K · filed 2025-09-30 | |
| 2024-12-31 | 99.63K CHF 20-F · filed 2025-05-15 | |
| 2024-06-30 | 100.58K CHF 6-K · filed 2025-09-30 | |
| 2023-12-31 | -312.60K CHF 20-F · filed 2025-05-15 | |
| 2023-06-30 | -149.39K CHF 6-K/A · filed 2023-12-21 | |
| 2022-12-31 | -215.53K CHF 20-F · filed 2025-05-15 | |
| 2022-06-30 | -116.98K CHF 6-K/A · filed 2023-12-21 | |
| 2021-12-31 | 132.05K CHF 20-F · filed 2024-04-18 | |
| 2021-06-30 | 328.98K CHF 6-K/A · filed 2022-09-14 | |
| 2020-12-31 | -686.89K CHF 20-F · filed 2023-03-30 | |
| 2019-12-31 | -234.66K CHF 20-F · filed 2022-03-10 |